Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
- Products
-
- Duloxetine Delayed-Release Capsules
- Where it was sold
-
PA, OH, PR
States: Ohio, Pennsylvania, Puerto Rico
- Units affected
- 37,916 bottles
- About this recall
- Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx only, 60 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-413-06